Ovarian cancer treatment with immunotherapy

Ovarian cancer treatment with immunotherapy can help to develop long-term control over the patient's disease. This treatment method uses both to prevent any possible complications and relapses after surgery and as a therapy to help the organism in detection and destroy cancer cells, even in the advanced stages. Immunotherapy activates the patient's immune system and increases immune cells' ability (primarily T-cells) to detect and kill cancer cells all over the organism. Doctors can prescribe immune therapy as a part of combined treatment and use it as a single method in rare cases. Most medications for ovarian cancer immunotherapy are various monoclonal antibodies. They are modified proteins of the immune system that seek the ovarian cancer cells all over the body and help deliver treatment substances to these cells or directly kill them. In addition, immune therapy often becomes a treatment method of choice for patients with recurrent ovarian cancer. Most often, medications for immunotherapy delivers via intravenous infusions. However, a single injection might take up to an hour. Unfortunately, a single infusion of immune therapy medications won't lead to a significant improvement. Therefore, a few consecutive courses (up to eight) might be required to achieve sustainable results.